Journal of Medicinal Chemistry human DNA repair proteins at a unique double-strand break in vivo. EMBO J. 2006, 25, 222−231. (24) Brooks, P. C.; Silletti, S.; von Schalscha, T. L.; Friedlander, M.; Cheresh, D. A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998, 92, 391−400. (25) Petitclerc, E.; Boutaud, A.; Prestayko, A.; Xu, J.; Sado, Y.; Ninomiya, Y.; Sarras, M. P., Jr.; Hudson, B. G.; Brooks, P. C. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. 2000, 275, 8051−8061. (26) Uchibayashi, T.; Lee, S. W.; Kunimi, K.; Ohkawa, M.; Endo, Y.; Noguchi, M.; Sasaki, T. Studies of eﬀects of anticancer agents in combination with/without hyperthermia on metastasized human bladder cancer cells in chick embryos using the polymerase chain reaction technique. Cancer Chemother. Pharmacol. 1994, 35, 84−87. (27) Petitclerc, E.; Deschesnes, R. G.; Cote, M. F.; Marquis, C.; Janvier, R.; Lacroix, J.; Miot-Noirault, E.; Legault, J.; Mounetou, E.; Madelmont, J. C.; C.-Gaudreault, R. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaﬀected by cell adhesion- mediated drug resistance. Cancer Res. 2004, 64, 4654−4663. (28) Lyu, M. A.; Choi, Y. K.; Park, B. N.; Kim, B. J.; Park, I. K.; Hyun, B. H.; Kook, Y. H. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeﬁcient mice. Int. J. Cancer 1998, 77, 257−263. (29) Kim, J.; Yu, W.; Kovalski, K.; Ossowski, L. Requirement for speciﬁc proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998, 94, 353−362. Article 6208 dx.doi.org/10.1021/jm3006492 | J. Med. Chem. 2012, 55, 6194−6208